Immutep IMMP
NASDAQ IMMP
$3.32 +0.09 (+2.79%)
As of: Oct 21, 2026 · 11:11 AM EDT

Immutep (IMMP) EBITDA (2013 - 2026)

Updated

Immutep (IMMP) reported EBITDA of -$56.12 million for the quarter ended Jun 30, 2026.

Analysis

Immutep (IMMP) EBITDA (2013 - 2026) Analysis & Trends

For the year ended Jun 30, 2026, Immutep posted EBITDA of -$54.55 million.

  • By year, EBITDA came in at -$37.84 million in the year ended Jun 30, 2025, -$26.68 million in the year ended Jun 30, 2024, -$25.3 million in the year ended Jun 30, 2023 and -$23.14 trillion in the year ended Jun 30, 2022.
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly EBITDA in data going back to the quarter ended Jun 30, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 9.10 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 8.33 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 5.09 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -9.70 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 5.89 Bn
10 Immutep 24.17 Mn -186.86 Mn - -56.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -56.12 Mn
Jun 30, 2017 1.16 Mn
Mar 31, 2017 -2.11 Mn
Jun 30, 2016 6.12 Bn
Mar 31, 2016 -2.33 Mn
Jun 30, 2015 -24.65 Mn
Jun 30, 2014 -11.98 Mn
Jun 30, 2013 -19.56 Mn
API Access

Immutep EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=IMMP&period=max&api_key=YOUR_API_KEY